KRISTIN RILEY: Open Payments
NPI 1336667732 · LAPEER, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$844 in 41 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $575 · 2025 $844
Food & beverage: $749Education: $95
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 17 | $323 |
| E.R. Squibb & Sons, L.L.C. | 8 | $148 |
| GENZYME CORPORATION | 2 | $112 |
| UCB, Inc. | 3 | $62 |
| Galderma Laboratories, L.P. | 3 | $57 |
| Amgen Inc. | 1 | $46 |
| Organon LLC | 5 | $43 |
| ABBVIE INC. | 1 | $30 |
| LEO Pharma Inc. | 1 | $21 |
Products named: COSENTYX, Sotyktu, DUPIXENT, Bimzelx, NEMLUVIO, OTEZLA, VTAMA, RINVOQ.
Industry payments across MI — which companies pay providers there.
